ONCOLOGY Vol 12 No 9 | Oncology

Phase I Clinical Data on Novel Anticancer, Antiangiogenesis Drug

September 01, 1998

Data from a phase I clinical trial of CT-2584, a novel small-molecule, anticancer, antiangiogenesis drug under investigation for the treatment of chemotherapy-resistant (advanced and refractory) cancers were presented at the 34th Annual Meeting of

Monoclonal Antibody May Increase Survival Rate in Patients With Colorectal Cancer

September 01, 1998

In patients with Dukes’ C colorectal cancer, therapy with a novel murine monoclonal antibody, Mab 17-1A (edrecolomab [Panorex]), manufactured by Centocor, reduced death by 32% and recurrence of disease by more than 23%, according to a

NCCN Receives $1 Million Grant to Support Oncology Outcomes Database

September 01, 1998

The National Comprehensive Cancer Network (NCCN) announced that it has received a $1 million dollar unrestricted grant from Genentech, Inc. The grant, which will be provided over a 2-year period, will be used to support the development and

Novel Tumor-Targeting Methods Show Promise

September 01, 1998

The results of six studies examining novel cancer-fighting approaches designed to target cancer cells while potentially leaving healthy cells intact were discussed at a press conference held at the 34th Annual Meeting of the American Society of Clinical

Combining Angiostatin With Radiation Enhances Anticancer Effects of Each

September 01, 1998

Adding low doses of angiostatin--a naturally produced substance that inhibits angiogenesis--to standard radiation therapy dramatically improves the response to cancer treatment in animal models without increasing toxicity, report researchers from

Role of Laparoscopy in the Staging of Gastrointestinal Cancer

September 01, 1998

Accurate staging plays a primary role in determining the appropriate treatment of gastrointestinal malignancies. Recently, laparoscopy has emerged as a staging modality that is more sensitive and specific in staging most

International Blood and Bone Marrow Registries Awarded $9.5 Million NIH Grant

September 01, 1998

Mary Horowitz, MD, MS scientific director of the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry (IBMTR/ABMTR) at the Medical College of Wisconsin, has been awarded a 5-year, $9.5

Lymphatic Mapping in the Treatment of Breast Cancer

September 01, 1998

Developed initially for the treatment of malignant melanoma, lymphatic mapping and sentinel lymph node biopsy have recently been introduced into the treatment of early breast cancer. In breast cancer patients, harvested

Epidemic Kaposi’s Sarcoma

September 01, 1998

Kaposi’s sarcoma (KS) is the most common malignancy associated with human immunodeficiency virus-1 (HIV-1) infection and can result in significant morbidity. The clinical course of KS is quite variable, although for the

Aggressive Pituitary Tumors

September 01, 1998

Although almost all pituitary tumors are benign adenomas, a surprisingly large number of these tumors invade tissues outside of the pituitary gland. Such invasion, by itself, is not diagnostic of pituitary carcinomas, which are

Lymphatic Mapping in the Treatment of Breast Cancer

September 01, 1998

Developed initially for the treatment of malignant melanoma, lymphatic mapping and sentinel lymph node biopsy have recently been introduced into the treatment of early breast cancer. In breast cancer patients, harvested

Epidemic Kaposi’s Sarcoma

September 01, 1998

Kaposi’s sarcoma (KS) is the most common malignancy associated with human immunodeficiency virus-1 (HIV-1) infection and can result in significant morbidity. The clinical course of KS is quite variable, although for the

Aggressive Pituitary Tumors

September 01, 1998

Although almost all pituitary tumors are benign adenomas, a surprisingly large number of these tumors invade tissues outside of the pituitary gland. Such invasion, by itself, is not diagnostic of pituitary carcinomas, which are

Epidemic Kaposi’s Sarcoma

September 01, 1998

Kaposi’s sarcoma (KS) is the most common malignancy associated with human immunodeficiency virus-1 (HIV-1) infection and can result in significant morbidity. The clinical course of KS is quite variable, although for the

Lymphatic Mapping in the Treatment of Breast Cancer

September 01, 1998

Developed initially for the treatment of malignant melanoma, lymphatic mapping and sentinel lymph node biopsy have recently been introduced into the treatment of early breast cancer. In breast cancer patients, harvested

List of Exchange Programs in Cancer Education

September 01, 1998

The World Health Organization (WHO) International Network for Cancer Education (INCE) is putting together a list of exchange programs in cancer education (eg, students, residents, faculty, and others) involving a European/US center and

Fred Hutchinson Receives $500,000 Bristol-Myers Squibb Unrestricted Grant

September 01, 1998

The Fred Hutchinson Cancer Research Center, which has one of the largest bone marrow transplantation program in the world, has received a $500,000 Bristol-Myers Squibb unrestricted cancer research grant to support its work on

Research May Provide Insights Into Best Treatment of Elderly Cancer Patients

September 01, 1998

New studies examining chemotherapy regimens for elderly patients with breast and lung cancer and data showing significant underrepresentation of the elderly in major clinical trials were discussed at a press conference at the 34th Annual Meeting of

Aggressive Pituitary Tumors

September 01, 1998

Although almost all pituitary tumors are benign adenomas, a surprisingly large number of these tumors invade tissues outside of the pituitary gland. Such invasion, by itself, is not diagnostic of pituitary carcinomas, which are

Role of Laparoscopy in the Staging of Gastrointestinal Cancer

September 01, 1998

Accurate staging plays a primary role in determining the appropriate treatment of gastrointestinal malignancies. Recently, laparoscopy has emerged as a staging modality that is more sensitive and specific in staging most